Intelligence · Clinical Pipeline
Denali Therapeutics Pipeline
All ClinicalTrials.gov programs at Denali Therapeutics — phase, modality, and trial IDs.
- Programs
- 4
Quick answer
Denali Therapeutics has 4 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
BIIB122
Denali Therapeutics
Parkinson Disease
2 trials -
DNL343
Denali Therapeutics
Amyotrophic Lateral Sclerosis
2 trials -
Elaprase 2 mg/ml concentrate for solution for infusion
Denali Therapeutics
Mucopolysaccharidosis Type II [MPS II]
1 trial -
tividenofusp alfa
Denali Therapeutics
Mucopolysaccharidosis II
3 trials
Frequently asked questions
How many pipeline programs does Denali Therapeutics have?
4 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs